MAFG-DT and Prostate Cancer Bone Metastasis
Author Information
Author(s): Wang Chongwen, Zhou Zheng, Ye Yongjie, Zhou Liqiang, Wang Jialun, Zhang Zhi
Primary Institution: Chengdu Fifth People’s Hospital, Chengdu, China
Hypothesis
The study investigates the role of MAFG-DT in promoting prostate cancer bone metastasis through the Wnt/β-catenin pathway.
Conclusion
MAFG-DT promotes prostate cancer progression and bone metastasis, suggesting it could be a potential therapeutic target.
Supporting Evidence
- MAFG-DT expression was significantly upregulated in prostate cancer tissues with bone metastasis.
- High levels of MAFG-DT were positively associated with poor prognostic outcomes in prostate cancer patients.
- Knockdown of MAFG-DT inhibited cellular proliferation, migration, invasion, and bone metastasis.
Takeaway
MAFG-DT is a molecule that helps prostate cancer spread to bones, and stopping it might help treat the cancer.
Methodology
The study used RT-qPCR, in situ hybridization, CCK8, EdU, colony formation, transwell assays, and a bone metastasis model with intracardiac injection to analyze MAFG-DT's role.
Participant Demographics
Patients undergoing surgery for prostate cancer at Chengdu Fifth People’s Hospital.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website